Insights

Innovative Mobility Cionic’s FDA-cleared Neural Sleeve 2 and its MultiStim system indicate a strong value proposition in neurotechnology-enabled mobility. Sales conversations can target health systems, rehabilitation centers, and MS organizations seeking advanced devices that improve motor function and quality of life.

Strategic Partnerships Recent collaboration with the National MS Society demonstrates opportunities to co-market and integrate care pathways. Leverage alliances to pursue funded programs, patient navigation support, and clinical adoption initiatives in neuroscience and rehabilitation networks.

Industry Recognition Being named one of World’s Most Innovative Companies and TIME Best Inventions highlights credibility with investors and procurement teams. Use prestige in outreach to accelerate pilot programs, grant applications, and hospital procurement cycles.

Growing Federation Revenue range and mid-size staffing suggest agility with scalable tech and services. Target mid-market healthcare providers, durable medical equipment distributors, and outpatient rehabilitation networks that can benefit from scalable neuralwear solutions.

Global Tech Stack A tech-forward approach with cloud analytics, AI, and Kubernetes supports data-driven outcomes and remote monitoring. Position offerings to software-led care platforms, digital therapeutic integrations, and enterprise analytics teams seeking value-based outcomes and interoperability.

Similar companies to CIONIC

CIONIC Tech Stack

CIONIC uses 8 technology products and services including LinkedIn Ads, Microsoft Advertising, Kubernetes, and more. Explore CIONIC's tech stack below.

Media & News

CIONIC's Email Address Formats

CIONIC uses at least 3 email formats:
CIONIC Email FormatsExamplePercentage
First@cionic.comJohn@cionic.com
92%
FLast@cionic.comJDoe@cionic.com
4%
FirstL@cionic.comJohnD@cionic.com
4%

Frequently Asked Questions

What is CIONIC's official website and social media links?

Minus sign iconPlus sign icon
CIONIC's official website is cionic.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does CIONIC generate?

Minus sign iconPlus sign icon
As of August 2026, CIONIC's annual revenue is estimated to be $10M - $25M.

What is CIONIC's SIC code and NAICS code?

Minus sign iconPlus sign icon
CIONIC's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CIONIC have currently?

Minus sign iconPlus sign icon
As of August 2026, CIONIC has approximately 26 employees across 2 continents, including North America and Europe. Key team members include Staff Engineer, Hardware And Embedded System: J. M. Explore CIONIC's employee directory with LeadIQ.

What industry does CIONIC belong to?

Minus sign iconPlus sign icon
CIONIC operates in the Biotechnology Research industry.

What technology does CIONIC use?

Minus sign iconPlus sign icon
CIONIC's tech stack includes LinkedIn Ads, Microsoft Advertising, Kubernetes, HubSpot Content Hub, Google BigQuery, HubSpot, Vercel and Piwik PRO Core.

What is CIONIC's email format?

Minus sign iconPlus sign icon
CIONIC's email format typically follows the pattern of First@cionic.com. Find more CIONIC email formats with LeadIQ.

How much funding has CIONIC raised to date?

Minus sign iconPlus sign icon
As of August 2026, CIONIC has raised $35M in funding. The last funding round occurred on Oct 18, 2023 for $12M.

When was CIONIC founded?

Minus sign iconPlus sign icon
CIONIC was founded in 2018.
CIONIC logo

CIONIC

Biotechnology ResearchCalifornia, United States11-50 Employees

Cionic is a San Francisco, California-based biotechnology research company developing wearable neurotechnology and connected care solutions. Its core offering, the Neural Sleeve 2, is FDA-cleared and designed to support movement by coordinating muscle activation with relaxation. The approach blends wearable hardware with adaptive software to address mobility across a range of conditions.

The company operates with a compact team and maintains collaborations with patient organizations, including a partnership with the National MS Society. In March 2026, Cionic launched the MultiStim system, an integrated stimulation platform that combines multiple pulse trains into a single pattern.

Section iconCompany Overview

Website
cionic.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $35M

    CIONIC has raised a total of $35M of funding over 5 rounds. Their latest funding round was raised on Oct 18, 2023 in the amount of $12M as a Series A.

  • $10M - $25M

    CIONIC's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.